NSclc Treatment

August 29, 2025

Overview of Lung Cancer

Charles H. Weaver, MD
August 21, 2025

Tagrisso – First Precision Medicine Approved for Treatment of Early Stage NSCLC

Charles H. Weaver, MD
December 5, 2024

NRG 1 Fusion Genes Can be Targeted with the Zenocutuzumab Bispecific Antibody

Charles H. Weaver, MD
November 1, 2023

CancerConnect – November is Lung Cancer Awareness Month

Charles H. Weaver, MD
October 27, 2023

Perioperative and Neoadjuvant Immunotherapy in Early Stage Lung Cancer

Charles H. Weaver, MD
October 24, 2023

Retevmo (selpercatinib) Treatment of Lung and Other “RET Fusion” Cancers

Charles H. Weaver, MD
October 17, 2023

Imfinzi in Non-Small Cell Lung Cancer

Charles H. Weaver, MD
October 12, 2023

Braftovi – Mektovi for Non-small cell lung cancer with a BRAF V600E Mutation

Charles H. Weaver, MD
September 14, 2023

Anti-TROP-2 Antibody Drug Conjugate Trodelvy Evaluated in Non-Small Cell Lung Cancer

Charles H. Weaver, MD
September 5, 2023

Datopotamab (Dato-Dxd) Treatment for Non-Small Cell Lung Cancer

Charles H. Weaver, MD
March 29, 2022

Diagnosed with Lung Cancer? 10 Must Read Tips to be an Empowered Patient

Charles H. Weaver, MD
March 11, 2022

Lung Cancer Surgery

Charles H. Weaver, MD